Before the MERS-CoV outbreak in 2012, we built a model using artificial intelligence (AI) tools for the identification of the levels of predicted intrinsic disorder (PID) in a query protein using its amino acid sequence as the only input \[[@B1-biomolecules-10-00331]\]. Next, this information was applied to rank various coronaviruses based on the levels of disorder in their inner and outer shells (i.e., PID values evaluated for their nucleocapsid (N) and membrane (M) proteins, respectively) and to find if these shell PID values were indicative of how long the given virus was able to stay in the environment \[[@B1-biomolecules-10-00331],[@B2-biomolecules-10-00331],[@B3-biomolecules-10-00331]\]. The application of this model ranked coronaviruses into three groups (Categories A, B, and C), members of which differ not only by the levels of their shell disorder, but also by their respiratory and fecal-oral transmission potential \[[@B1-biomolecules-10-00331],[@B2-biomolecules-10-00331],[@B3-biomolecules-10-00331]\]. The model was consistent with the hypothesis that viruses remaining in harsh environments require harder, i.e., less disordered, shells to survive \[[@B2-biomolecules-10-00331],[@B3-biomolecules-10-00331]\]. Furthermore, higher levels of inner shell disorder could be associated with greater infectivity, especially with regard to the viruses with high respiratory transmission potential \[[@B3-biomolecules-10-00331],[@B4-biomolecules-10-00331],[@B5-biomolecules-10-00331]\].

On the basis of these considerations, Category A coronaviruses are characterized by more disordered inner (N) shell and higher levels of respiratory transmission combined with lower levels of fecal-oral transmission. Category B coronaviruses are characterized by the N shell having intermediate levels of disorder and intermediate levels of respiratory and fecal-oral transmission, whereas Category C coronaviruses possess the most ordered N proteins and are characterized by higher levels of fecal-oral transmission and lower levels of respiratory transmission \[[@B1-biomolecules-10-00331],[@B2-biomolecules-10-00331],[@B3-biomolecules-10-00331],[@B4-biomolecules-10-00331],[@B5-biomolecules-10-00331]\]. Notably, some (not all) of the viruses with lower outer shell rigidity (higher M PID) are in Category C with greater fecal-oral transmission potential because these viruses do not have to be in the environment for a long time given that the fecal-oral route is an efficient mode of transmission among some farm animals.

According to this PID-based classification, SARS-CoV (with PIDs of 9% and 50% for its M and N proteins, respectively) falls into Category B, which includes the coronaviruses with the intermediate levels of both respiratory and fecal-oral potential. However, MERS-CoV, whose M and N proteins are characterized by the PID values of 10% and 44%, respectively, were placed into a group with a higher fecal-oral and lower respiratory transmission potential, Category C \[[@B5-biomolecules-10-00331]\]. Importantly, this classification of coronaviruses which is based on the rigidity of their shells was generally supported by clinical observations of their transmission modes.

The usefulness of our model is now becoming obvious, considering the current COVID-19/Wuhan 2019-nCoV outbreak \[[@B6-biomolecules-10-00331]\]. Currently, the analysis suggests (details of this analysis will be published elsewhere \[[@B7-biomolecules-10-00331]\]) that COVID-19/Wuhan 2019-nCoV belongs to Category B, indicating that, similar to SARS-CoV, COVID-19/Wuhan 2019-nCoV can be efficiently transmitted via the respiratory mode. However, due to the fact that the outer shell of this virus is among the hardest in the coronavirus family, the model suggests that COVID-19/Wuhan 2019-nCoV is likely to be more resilient in body fluids and the environment than most of its cousins, including SARS-CoV and MERS-CoV.

Therefore, our model predicts that COVID-19/Wuhan 2019-nCoV can be efficiently spread by respiratory means, as in the case of SARS-CoV, but it also has the potential to remain outside the body longer than SARS-CoV, and, probably, MERS-CoV. The possibility of fecal-respiratory transmission of COVID-19/Wuhan 2019-nCoV is especially of concern, as was the case for SARS-CoV in the Amoy Garden, Hong Kong3. Furthermore, the intermediate levels of fecal-oral transmission potential of COVID-19/Wuhan 2019-nCoV should also be kept in mind, as in the case of all other viruses in Category B.

Although the ability to last longer outside the body provides better fitness of the virus that relies more on the fecal-respiratory route of transmission, as seen in PEDV3,5, transmission of the more rigid virus can occur via feces, but also in airborne form released from mucus, vomit, and other body fluids. These properties can also explain the higher contagiousness levels of the COVID-19/Wuhan 2019-nCoV than with SARS-CoV \[[@B6-biomolecules-10-00331]\]. In fact, the ability of COVID-19/Wuhan 2019-nCoV to remain infectious outside the body for a longer period than SARS-CoV could imply that it requires fewer viral particles for greater chances of infection. Furthermore, an infected body can shed more active viral particles in greater concentrations as more particles are able to resist the digestive enzymes found in most bodily fluids including saliva \[[@B2-biomolecules-10-00331],[@B3-biomolecules-10-00331]\]. All these can explain not only high contagiousness of the COVID-19/Wuhan 2019-nCoV but also the reported capability of this virus to be spread even before the patient begins to show symptoms \[[@B6-biomolecules-10-00331]\].
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